Multiple Sclerosis Implementation Network (Registry)
Sponsored by The University of Texas Health Science Center, Houston
About this study
The Multiple Sclerosis Implementation Network (MSIN) is a collaboration between the Multiple Sclerosis Association of America (MSAA), The University of Texas Health Science Center at Houston (UTHealth Houston), Dell Medical School at The University of Texas at Austin, and Novartis Pharmaceuticals Corporation. The goal of MSIN is to improve Multiple Sclerosis (MS) care, patient health, and quality of life through the development and support of implementation research and clinical practice collaboration. MSIN brings together healthcare teams, people with MS, and research leaders in MS and implementation science (IS) to learn, share, test, implement, and disseminate innovations that improve MS care, patient health, and quality of life. This ClinicalTrials.gov record pertains to the MSIN Patient Registry, which is a comprehensive database that integrates participants' electronic health records from various providers.
Where this study is enrolling (3)
- I'm interested
Multiple Sclerosis Association of America
Cherry Hill, New Jersey
- I'm interested
The University of Texas at Austin
Austin, Texas
- I'm interested
The University of Texas Health Science Center at Houston (UTHealth Houston)
Houston, Texas
Who can participate
Inclusion criteria
- ✓diagnosed with Multiple Sclerosis
- ✓can speak and understand English comfortably
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.